ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 359415 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 359415; 2) Community: the network communities that were significantly associated with the response to NSC 359415; 3) Molecule: the relationships between components within communities and NSC 359415; 4) MDR: the compounds that were significantly associated with the NSC 359415.

NSC Compound Enrichment Correlation
NSC 695164 2-Propen-1-one, 1-(2-benzimidazolyl)-3-(4-nitrophenyl)- 0.000710545569439728 -0.042647485
NSC 720340 Null 0.000710545569439728 0.32335621
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.000710545569439728 0.35675631
NSC 747292 Null 0.000710545569439728 0.42347302
NSC 755417 Null 0.000710545569439728 0.40815935
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.000778243021198128 0.10108762
NSC 621335 Null 0.000778243021198128 0.023148823
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.000778243021198128 0.25315914
NSC 677256 Null 0.000778243021198128 0.17184583
NSC 685833 7H-Purine, 2,6-dichloro- 7-[2-deoxy-3,5-O-bis(4-methylphenyl)- .beta.-D-ribofuranosyl]- 0.000778243021198128 0.33541572
Total:139  Current:10    [First] [Prev] [Next] [Last]